|
Market Closed -
NYSE
04:00:02 2026-11-17 pm EST
|
5-day change | 1st Jan Change | ||
| 1.350 USD | +8.00% |
|
-10.60% | -61.76% |
| Market Cap | 190M 172M 159M 144M 271M 17.74B 282M 1.92B 759M 9.57B 712M 697M 30.25B | P/E 2026 * |
-1.94x | P/E 2027 * | -2.1x |
|---|---|---|---|---|---|
| Enterprise Value | 190M 172M 159M 144M 271M 17.74B 282M 1.92B 759M 9.57B 712M 697M 30.25B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 1.87x |
| Free-Float |
85.18% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ADCT | Delayed | |
| ADCT | Real-time |
Last Transcript: ADC Therapeutics SA
| 1 day | +8.00% | ||
| 1 week | -10.60% | ||
| Current month | -11.76% | ||
| 1 month | -3.57% | ||
| 3 months | +22.73% | ||
| 6 months | -58.46% | ||
| Current year | -61.76% |
| 1 week | 1.24 | 1.58 | |
| 1 month | 1.24 | 1.86 | |
| Current year | 0.78 | 4.98 | |
| 1 year | 0.78 | 4.98 | |
| 3 years | 0.68 | 6.04 | |
| 5 years | 0.36 | 24.82 | |
| 10 years | 0.36 | 56.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ameet Mallik
CEO | Chief Executive Officer | 53 | 2022-05-08 |
Jose Carmona
DFI | Director of Finance/CFO | 54 | 2022-12-18 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 52 | 2024-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Tim Coughlin
BRD | Director/Board Member | 59 | 2025-05-31 |
Peter Hug
BRD | Director/Board Member | 67 | 2019-05-31 |
Ron Squarer
CHM | Chairman | 59 | 2020-02-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/30/26 | Free | Chief Executive Officer | 675,000 | 0.5307% | ||
| 6/30/26 | Free | Chief Financial Officer | 203,700 | 0.1602% | ||
| 6/30/26 | Free | Chief Technology Officer | 213,900 | 0.1682% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +8.00% | -10.60% | -65.99% | +91.87% | 190M | ||
| +1.15% | -2.81% | +55.79% | +71.12% | 66.37B | ||
| +0.87% | -1.55% | +9.28% | +91.21% | 58.86B | ||
| +0.84% | +0.63% | +26.19% | +86.95% | 55.22B | ||
| +0.48% | -2.53% | +9.73% | +121.14% | 47.21B | ||
| -2.69% | -6.38% | +19.19% | +25.79% | 42.45B | ||
| -0.70% | +4.93% | +17.77% | +45.03% | 36.44B | ||
| -2.50% | -15.73% | +135.31% | +662.73% | 35.19B | ||
| -0.13% | -2.08% | +81.99% | +57.07% | 32.66B | ||
| -0.83% | +1.98% | -38.27% | +390.98% | 26.73B | ||
| Average | +0.45% | -4.57% | +25.10% | +164.39% | 40B | |
| Weighted average by Cap. | -0.14% | -2.19% | +34.94% | +147.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 87.22M 79.18M 73.14M 65.99M 125M 8.15B 129M 881M 349M 4.4B 327M 320M 13.89B | 101M 92.07M 85.05M 76.73M 145M 9.48B 150M 1.02B 405M 5.11B 381M 373M 16.16B |
| Net income | -109M -99.32M -91.75M -82.77M -156M -10.22B -162M -1.11B -437M -5.52B -410M -402M -17.43B | -123M -112M -103M -93.32M -176M -11.52B -183M -1.25B -493M -6.22B -463M -453M -19.65B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-17 | $1.350 | +8.00% | 1,097,116 |
| 26-11-16 | $1.250 | -6.72% | 1,480,602 |
| 26-11-13 | $1.340 | -4.96% | 1,075,046 |
| 26-11-12 | $1.410 | -11.88% | 1,874,102 |
| 26-11-11 | $1.600 | +5.96% | 769,034 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- ADCT Stock
Select your edition
All financial news and data tailored to specific country editions
















